Senators Question Pfizer, Mylan, Others on Drug Pricing

Two senators wrote to five companies asking them to explain price changes to the naloxone

June 8, 2016

U.S. senators asked five drugmakers to explain increases in the price of naloxone, a drug that is used to reverse the effects of opioids, according to a Bloomberg article. The senators also want to know what the companies are doing to preserve access to the drug, which hospitals have said they’ve had trouble obtaining.

Senators Susan Collins, a Maine Republican, and Claire McCaskill, a Missouri Democrat, wrote to Pfizer Inc., Mylan NV, Amphastar Pharmaceuticals Inc., Adapt Pharma Inc. and Kaleo Inc., asking them to explain price changes for naloxone, the story said. They cited a report in Politico that at least one version of the drug has risen in price by as much as 17-fold in the last two years.

Read the Bloomberg article